Applications

1622 – Cardiac ablation devices for use in ventricular arrhythmia and supraventricular tachycardia

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type -
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Supported

Application details

Reason for application

To provide advice to the Prostheses List Advisory Committee (PLAC) on the comparative clinical and cost-effectiveness of cardiac ablation devices for use in ventricular arrhythmia and supraventricular tachycardia.

Service or technology in this application

Cardiac ablation devices for use in ventricular arrhythmia (VA) and supraventricular tachycardia (SVT).

Type: Therapeutic

Medical condition this application addresses

Patients with symptomatic VA or non-atrial fibrillation SVT. A cardiac arrhythmia is a condition where a person’s heart beats too fast (tachycardia), too slow (bradycardia), or with an irregular rhythm. This results from a disruption of the electrical conduction of the heart and may occur in brief episodes (paroxysmal), or it may be a longer-term or permanent condition.

Meetings to consider this application

  • PASC meeting: -
  • ESC meeting: 12 June 2020
  • MSAC meeting: 28 to 29 July 2020